{"id":2736,"date":"2022-01-21T21:50:00","date_gmt":"2022-01-21T21:50:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/"},"modified":"2022-01-21T21:50:00","modified_gmt":"2022-01-21T21:50:00","slug":"xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/","title":{"rendered":"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>XVIVO kan idag stolt meddela att US Food &amp; Drug Administration (FDA) har beviljat godk\u00e4nnande f\u00f6r Kidney Assist Transport. Organdonatorer och mottagare av organ befinner sig s\u00e4llan p\u00e5 samma sjukhus och d\u00e4rf\u00f6r beh\u00f6ver organ transporteras p\u00e5 ett s\u00e4kert och tillf\u00f6rlitligt s\u00e4tt. Kidney Assist Transport \u00e4r ett portabelt system f\u00f6r maskinperfusion av njurar. Den m\u00f6jligg\u00f6r kontinuerlig syres\u00e4ttning i upp till 24 timmar vilket har visat sig f\u00f6rb\u00e4ttra bevarandet av njurar j\u00e4mf\u00f6rt med traditionell kall f\u00f6rvaring.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Enligt V\u00e4rldsh\u00e4lsoorganisationen (WHO) \u00e4r njursjukdomar v\u00e4rldens 10:e vanligaste d\u00f6dsorsak. Patienter med njursjukdomar i slutstadiet beh\u00f6ver regelbunden dialys eller en njurtransplantation f\u00f6r att \u00f6verleva. Transplantation \u00e4r den f\u00f6redragna behandlingen eftersom den f\u00f6rb\u00e4ttrar patientens livskvalitet och \u00f6verlevnad. Njurtransplantation \u00e4r ocks\u00e5 ett mycket mer kostnadseffektivt behandlingsalternativ \u00e4n dialys. Idag \u00e4r USA den st\u00f6rsta marknaden med cirka 18 700 njurtransplantationer fr\u00e5n avlidna donatorer under 2021, och det finns f\u00f6r n\u00e4rvarande mer \u00e4n 90 000 patienter p\u00e5 v\u00e4ntelistan f\u00f6r en ny njure. Behovet av tillg\u00e4ngliga organ \u00f6verstiger markant tillg\u00e5ngen.<\/p>\n<p>En nyligen publicerad artikel i den vetenskapliga tidskriften The Lancet p\u00e5visar att genom syresatt hypotermisk maskinperfusion med Kidney Assist Transport, kan man minska allvarliga komplikationer f\u00f6r patienten, undvika extra diagnostiska utredningar och minska antalet fall d\u00e4r patienter \u00e5terinl\u00e4ggs in p\u00e5 sjukhus. \u00c4ven kostnaden f\u00f6r dialys f\u00f6r kroniskt sjuka patienter kan undvikas<a href=\"http:\/\/#_ftn1\" target=\"_blank\" rel=\"nofollow noopener\">[1]<\/a>.<\/p>\n<p>&#34;Redan innan lansering s\u00e5 har det varit ett enormt intresse f\u00f6r Kidney Assist Transport och vi som organisation \u00e4r nu mycket glada \u00f6ver att kunna erbjuda denna produkt till marknaden. Vi kommer att p\u00e5b\u00f6rja lanseringen regionalt f\u00f6r att sedan skala upp under \u00e5ret\u201d, s\u00e4ger Managing Director f\u00f6r Nordamerika Fredrik Dalborg.<\/p>\n<p>\u201dVi etablerar nu en stark kommersiell n\u00e4rvaro i USA inom abdominal transplantation med fokus p\u00e5 njurar. V\u00e5r strategi \u00e4r att bli global ledare inom abdominalomr\u00e5det och Kidney Assist Transport \u00e4r en nyckel f\u00f6r att g\u00f6ra det m\u00f6jligt. Jag k\u00e4nner mig hedrad \u00f6ver att vi idag kan lansera denna fantastiska produkt efter flera \u00e5r av kontinuerlig utveckling och flertalet kliniska pr\u00f6vningar. Kidney Assist Transport kommer att m\u00f6jligg\u00f6ra s\u00e5 att fler njurar blir tillg\u00e4ngliga f\u00f6r transplantation\u201d, s\u00e4ger Dag Andersson, VD f\u00f6r XVIVO.<br \/>\u00a0<br \/>21 januari, 2022<br \/>G\u00f6teborg<br \/>Dag Andersson, CEO<br \/>XVIVO Perfusion AB (publ)<\/p>\n<hr\/>\n<p><a href=\"http:\/\/#_ftnref1\" target=\"_blank\" rel=\"nofollow noopener\">[1]<\/a> Johmanns I, et al. Oxygenated versus standard cold perfusion preservation<br \/>in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial. The Lancet. November 2020;396 (10263):1653-1662.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n<hr\/>\n<p>Dag Andersson, VD, +46 31-788 21 50,\u00a0dag.andersson@xvivogroup.com<br \/>Kristoffer\u00a0Nordstr\u00f6m,\u00a0CFO, +46 73-519 21 64,\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><\/p>\n<hr\/>\n<p>XVIVO grundades 1998 och \u00e4r ett medicintekniskt f\u00f6retag dedikerat till att f\u00f6rl\u00e4nga livet f\u00f6r donerade organ s\u00e5 att transplantationsteam runt om i v\u00e4rlden kan r\u00e4dda fler liv. V\u00e5ra l\u00f6sningar g\u00f6r det m\u00f6jligt f\u00f6r ledande kliniker och forskare att t\u00e4nja p\u00e5 gr\u00e4nserna f\u00f6r transplantationsmedicin.\u00a0XVIVO har sitt huvudkontor i G\u00f6teborg och har kontor och forskningsanl\u00e4ggningar p\u00e5 tv\u00e5 kontinenter. Bolaget \u00e4r noterat p\u00e5 Nasdaq Stockholm\u00a0och handlas under symbolen XVIVO. Mer information finns att l\u00e4sa p\u00e5 hemsidan www.xvivogroup.com\/us<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-mar\">\n<p><em>Denna information \u00e4r s\u00e5dan information som XVIVO Perfusion AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 2022-01-21 22:50 CET.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/fa1a3bdb-7dcd-4495-a095-34d7058e132b\/xvivos-kidney-assist-transport-far-510-k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa.pdf\" target=\"_blank\" rel=\"nofollow noopener\">XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO kan idag stolt meddela att US Food &amp; Drug Administration (FDA) har beviljat godk\u00e4nnande f\u00f6r Kidney Assist Transport. Organdonatorer&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2736","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO kan idag stolt meddela att US Food &amp; Drug Administration (FDA) har beviljat godk\u00e4nnande f\u00f6r Kidney Assist Transport. Organdonatorer...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\\\/\",\"name\":\"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-01-21T21:50:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/","og_locale":"en_US","og_type":"article","og_title":"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA - XVIVO","og_description":"XVIVO kan idag stolt meddela att US Food &amp; Drug Administration (FDA) har beviljat godk\u00e4nnande f\u00f6r Kidney Assist Transport. Organdonatorer...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/","name":"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-01-21T21:50:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-kidney-assist-transport-far-510k-godkannande-av-amerikanska-fda-och-blir-xvivos-forsta-regulatoriskt-godkanda-produkt-for-transplantation-av-abdominala-organ-i-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVOs Kidney Assist Transport f\u00e5r 510(k)-godk\u00e4nnande av amerikanska FDA och blir XVIVOs f\u00f6rsta regulatoriskt godk\u00e4nda produkt f\u00f6r transplantation av abdominala organ i USA"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}